Short-term IL-1Β blockade reduces monocyte CD11b integrin expression in an IL-8 dependent fashion in patients with type 1 diabetes

Clinical Immunology

Volumn 136, Issue 2, 2010, Pages 170-173

  Sanda, Srinath ^a   Bollyky, Jenna ^a   Standifer, Nathan ^a   Nepom, Gerald ^a   Hamerman, Jessica A ^a   Greenbaum, Carla ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Cytokines; Monocyte; Type 1 diabetes

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CXCR1; INTERLEUKIN 1BETA; INTERLEUKIN 8; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG MECHANISM; HUMAN; HUMAN CELL; INJECTION SITE REACTION; INSULIN DEPENDENT DIABETES MELLITUS; MONOCYTE; MORNING DOSAGE; PANCREAS ISLET CELL FUNCTION; PAPULE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE DRUG DOSE;

ADOLESCENT; ADULT; ANTIGENS, CD11B; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; INTERLEUKIN-8; MIDDLE AGED; MONOCYTES; YOUNG ADULT;

EID: 77954311838     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.04.009     Document Type: Article

References (12)

1. Maedler K., Sergeev P., Ris F., et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. Journal of Clinical Investigation 2002, 110(6):851-860.
2. Larsen C.M., Faulenbach M., Vaag A., et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. New England Journal of Medicine 2007, 356(15):1517-1526.
3. Kaizer E.C., Glaser C.L., Chaussabel D., et al. Gene expression in peripheral blood mononuclear cells from children with diabetes. Journal of Clinical Endocrinology and Metabolism 2007, 92(9):3705-3711.
4. Pfleger C., Mortensen H.B., Hansen L., et al. Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes. Diabetes 2008, 57(4):929-937.
5. Greenbaum C., Seidel K., Pihoker C. The case for intravenous arginine stimulation in lieu of mixed-meal tolerance tests as outcome measure for intervention studies in recent-onset type 1 diabetes. Diabetes Care 2004, 27(5):1202-1204.
6. Feniger-Barish R., Ran M., Zaslaver A., et al. Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2. Cytokine 1999, 11(12):996-1009.
7. Liebler J.M., Kunkel S.L., Burdick M.D., et al. Production of IL-8 and monocyte chemotactic peptide-1 by peripheral blood monocytes. Disparate responses to phytohemagglutinin and lipopolysaccharide. Journal of Immunology 1994, 152(1):241-249.
8. Carroll T.P., Greene C.M., Taggart C., et al. Viral inhibition of IL-1- and neutrophil elastase-induced inflammatory responses in bronchial epithelial cells. Journal of Immunology 2005, 175(11):7594-7601.
9. Drost E.M., MacNee W. Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. European Journal of Immunology 2002, 32(2):393-403.
10. Greenbaum C.J., Anderson A.M., Dolan L.M., et al. Preservation of beta-cell function in autoantibody-positive youth with diabetes. Diabetes Care 2009, 32(10):1839-1844.
11. Bai Y., Robinson E., Chai R., et al. Immunohistochemical study of monocyte chemoattractant protein-1 in the pancreas of NOD mice following cyclophosphamide administration and during spontaneous diabetes. Journal of Molecular Histology 2006, 37(3-4):101-113.
12. Solomon M., Balasa B., Sarvetnick N. CCR2 and CCR5 chemokine receptors differentially influence the development of autoimmune diabetes in the NOD mouse. Autoimmunity 2010, 43(2):156-163.